Medical Advocates
HCV Infection/Disease
 
Clinical Variants
 
General Reports
 Angiomyolipoma
 Biliary Disorders
Cirrhosis
Cholestatic Hepatitis
Cytopenia
Fibrosis
 Hepatocellular Carcinoma
Infl. Bowel Disease
Metabolic Disorders		 Non-Alcoholic Fatty Liver Disease
 Oncological Disorders 
Purpura
 Post Transplantation HCV
Renal Disease
Splenic Disease
Statin Hepatotoxicity
Steatosis

 
HCV Main Page Main New/Newsworthy    Home Page    
Last Update:  February 03, 2012
   Documents identified with this icon are in Portable Document Format (PDF) and require the Adobe Acrobat Reader
General/Miscellaneous Reports
 
 

A case of MPO-ANCA-positive Wegener's granulomatosis with hepatitis C virus infection
Yasuda M, Araki H, Fujitomo Y,
Nihon Jinzo Gakkai Shi. 2011;53(7):1053-8
 Abstract

Influence of hepatitis C virus on neurocognitive function in patients free from other risk factors: validation from therapeutic outcomes.
Pattullo V, McAndrews MP, Damyanovich A, Heathcote EJ.
 Liver Int. 2011 Aug;31(7):1028-38
 Abstract

Lymphocytosis as a predictor of poor response to treatment of hepatitis C.
Martinez-Camacho A, Khaoustov VI, Adam E,
 Gastroenterol Clin Biol. 2010 Dec 22.
 Abstract

Cutaneous sarcoidosis in a woman with chronic hepatitis C and interferon therapy:
a case report.
Song K, Das K.
Acta Cytol. 2010 Sep-Oct;54(5 Suppl):863-6.
 Abstract

Biomarkers of fibrosis and impaired liver function in chronic hepatitis C: how well
do they predict clinical outcomes?
 Peters L, Rockstroh JK.
Curr Opin HIV AIDS. 2010 Nov;5(6):517-23.
 Abstract

Prevalence and Challenges of Liver Diseases in Patients with Chronic Hepatitis C Virus
Infection.
 Jacobson IM, Davis GL, El-Serag H, et al
 Clin Gastroenterol Hepatol. 2010 Aug 13
Abstract

Gilbert's syndrome and antiviral therapy of hepatitis C.
 Deterding K, Grüngreiff K, Lankisch TO, et al
Ann Hepatol. 2009 Jul-Sep;8(3):246-50
 Abstract
 
Angiomyolipoma
 
  Hepatic angiomyolipoma in two patients infected with hepatitis C virus.
 Bilbao I, Castro E, Dopazo C, et al  
Gastroenterol Hepatol. 2007 Apr;30(4):222-8
Abstract		  
Biliary Disorders
 
  Role of a Short-Term Stent-Trial in a Patient with Biliary Stricture and Portal
Hypertensive Biliopathy: Long-Term Outcome Result.
 Cantù P, Bezzio C.
 Dig Dis Sci. 2010 Aug 19.
Abstract		  
Cholestatic Hepatitis
 
     Journal Papers, Abstracts, and Commentaries
 
 
Early diagnosis and treatment resolved cholestatic hepatitis C without fibrosis
after living donor liver transplantation: Report of a case.
Fukuhara T, Morita K, Takeishi K,  et al
Surg Today. 2010 Oct;40(10):982-985
 Abstract

Fatal hepatitis C associated fibrosing cholestatic hepatitis as a complication of
cyclophosphamide and corticosteroid treatment of active glomerulonephritis.
Saleh F, Ko HH, Davis JE, Apiratpracha W, et al
 Ann Hepatol. 2007 Jul-Sep;6(3):186-9
Abstract

  
Cirrhosis
 
 
Impact of delayed diagnosis time in estimating progression rates to hepatitis C virus-related cirrhosis
and death.
Fu B, Wang W, Shi X.
 Stat Methods Med Res. 2011 Oct 18      
 Abstract
 

Response to standard of care antiviral treatment in patients with HCV liver cirrhosis -
a systematic review.
Bota S, Sporea I, Popescu A, Sirli R
J Gastrointestin Liver Dis. 2011 Sep;20(3):293-8.
 Abstract

Survival rates of early-stage HCV-related liver cirrhosis patients without hepatocellular carcinoma are
decreased by alcohol.
 Yamada M, Shiroeda H, Hayashi R,  et et al
J Clin Biochem Nutr. 2011 Mar;48(2):167-9
 Abstract

Serum cytokine levels as putative prognostic markers in the progression of chronic HCV
hepatitis to cirrhosis.
 Costantini S, Capone F, Guerriero E, et al
Eur Cytokine Netw. 2010 Nov 17
 Abstract

Antiviral therapy in HCV-infected decompensated cirrhotics.
Danish FA, Koul SS, Subhani FR, et al
 Saudi J Gastroenterol. 2010 Oct-Dec;16(4):310-4.
 Abstract

Incidence of liver cirrhosis in HIV-infected patients with chronic hepatitis B or C in the era of
highly active antiretroviral therapy.[Spain]
Tuma P, Medrano J, Resino S,  et al
Antivir Ther. 2010;15(6):881-6
 Abstract

Peginterferon Plus Ribavirin and Sustained Virological Response in HCV-Related
Cirrhosis: Outcomes and Factors Predicting Response.
 Fernández-Rodríguez CM, Alonso S, Martinez SM,  et al
Am J Gastroenterol. 2010 Aug 10
 Abstract

Antiviral therapy reduces risk of hepatocellular carcinoma in patients with hepatitis C
virus-related cirrhosis.
Singal AK, Singh A, Jaganmohan  et al
Clin Gastroenterol Hepatol. 2009 Oct 29
 Abstract

Natural History of Compensated Hepatitis C Virus-Related Cirrhosis in HIV-Infected Patients.
 Pineda JA, Aguilar-Guisado M, Rivero A, et al  
Clin Infect Dis. 2009 Sep 22
 Abstract

Radiofrequency Ablation as a Palliative Treatment of Primary Liver Sarcoma in an Inoperable Patient
with Hepatitis C Virus-Related Cirrhosis.
 Chen JH, Chang PY, Ho CL, Chen PJ
Onkologie. 2009;32(8-9):509-512
 Abstract

Management and Treatment of Patients With Cirrhosis and Portal Hypertension:
Recommendations From the Department of Veterans Affairs Hepatitis C Resource
Center Program and the National Hepatitis C Program.
 Garcia-Tsao G, Lim J.  
 Am J Gastroenterol. 2009 May 19
 Abstract

Sustained virologic responses following standard antiviral therapy in decompensated HCV-infected
cirrhotic patients.
 Iacobellis A, Siciliano M, Annicchiarico BE, et al
Aliment Pharmacol Ther. 2009 Apr 17
 Abstract

Predicting Mortality Risk in Patients With Compensated HCV-Induced Cirrhosis:
A Long-Term Prospective Study.
 Bruno S, Zuin M, Crosignani A,  et al  
Am J Gastroenterol. 2009 Apr 7
 Abstract

Does cirrhosis affect quality of life in hepatitis C virus-infected patients?
 Hsu PC, Krajden M, Yoshida EM, et al
Liver Int. 2009 Mar;29(3):449-58.
 Abstract
 
Portal vein thrombosis in a patient with hepatitis C virus-related cirrhosis complicated
with antiphospholipid syndrome.
 Kida Y, Maeshima E, Yamada Y.
Rheumatol Int. 2009 Jan 28.
Abstract
 
Antiviral therapy in hepatitis C virus cirrhotic patients in compensated and decompensated condition.
 Iacobellis A, Ippolito A, Andriulli A.
World J Gastroenterol. 2008 Nov 14;14(42):6467-72.
 Abstract
 
Clinical outcome of HCV-related graft cirrhosis and prognostic value of hepatic venous pressure gradient.
 Kalambokis G, Manousou P, Samonakis D, et al 
Transpl Int. 2008 Sep 10
 Abstract

Hepatitis C virus cirrhosis: prolonged sustained virological response in a patient after
low-dose antiviral treatment.
 Abenavoli L, De Maria V, De Siena M, et al 
Minerva Gastroenterol Dietol. 2008 Jun;54(2):219-24
 Abstract

Antiviral treatment in patients with hepatitis C virus-related cirrhosis awaiting liver transplantation.
 Toniutto P, Fabris C, Bitetto D, et al
 Ther Clin Risk Manag. 2008 Jun;4(3):599-603.
 Abstract
Impact of cirrhosis on outcomes in trauma.
 Dangleben DA, Jazaeri O, Wasser T, et al
 J Am Coll Surg. 2006 Dec;203(6):908-13.
 Abstract
 
Hepatic encephalopathy with status epileptics: A case report.
 Tanaka H, Ueda H, Kida Y,et al 
World J Gastroenterol. 2006 Mar 21;12(11):1793-4.
 Abstract
 
A predictive index for the diagnosis of cirrhosis in hepatitis C based on clinical, laboratory,
and ultrasound findings.
 Obrador BD, Prades MG, Gomez MV
 Eur J Gastroenterol Hepatol. 2006 Jan;18(1):57-62.
 Abstract
 
Comprehensive clinical assessment improves the accuracy of predicting cirrhosis in chronic
hepatitis C.
 Gordon A, Bailey MJ, Gibson PR, Roberts SK.
Gastroenterol Hepatol. 2005 Jun;20(6):825-32
 Abstract
 
Interferon plus ribavirin and interferon alone in preventing hepatocellular carcinoma:
A prospective study on patients with HCV related cirrhosis.
 Francesco A, Esterita A, Giovanni N, et al 
World J Gastroenterol. 2004 Nov 1;10(21):3099-3102.
 Abstract
 
FULL-TEXT PDF ARTICLE
 Treatment of chronic hepatitis C in patients with decompensated cirrhosis.
 Everson GT.
Rev Gastroenterol Disord. 2004;4 Suppl 1:S31-8.
Paper
 
Treatment considerations in patients with hepatitis C and cirrhosis.
 Heathcote EJ.
 J Clin Gastroenterol. 2003 Nov-Dec;37(5):395-8.
 Abstract
 
Is laparoscopy an advantage in the diagnosis of cirrhosis in chronic hepatitis C virus infection?
 Wietzke-Braun P, Braun F, Schott P, Ramadori G.
 World J Gastroenterol 2003 Apr;9(4):745-50
 Abstract
 
Treatment of patients with hepatitis C and cirrhosis.
 Wright TL.
 Hepatology 2002 Nov;36(5 Suppl 1):S185-94
 Abstract
Cytopenia
 
     Journal Papers, Abstracts, and Commentaries
 
Severe autoimmune cytopenias in treatment-naive hepatitis C virus  infection:
clinical description of 35 cases. 
Ramos-Casals M,Garcia-Carrasco M, Lopez-Medrano F, et al
Medicine (Baltimore) 2003 Mar;82(2):87-96
Abstract
Hepatocellular Carcinoma
 
     Journal Papers, Abstracts, and Commentaries
 
Hepatitis C virus to hepatocellular carcinoma.
Jahan S, Ashfaq UA, Qasim M,  et al
 Infect Agent Cancer. 2012 Jan 30;
 Abstract

The influence of postoperative glycemic control on recurrence after curative resection in diabetics with
hepatitis C virus-related hepatocellular carcinoma.
Kaneda K, Uenishi T, Takemura S, et al
J Surg Oncol. 2011 Nov 7.
 Abstract

Chronic Hepatitis C Genotype-4 Infection: Role of Insulin Resistance in Hepatocellular Carcinoma.
Mohamed AA, Loutfy SA, Craik JD, et al
Virol J. 2011 Nov 1;8(1):496
 Abstract

Genetic risk of hepatocellular carcinoma in patients with hepatitis C virus: a case control study.
Tomoda T, Nouso K, Sakai A,  et al
J Gastroenterol Hepatol. 2011 Oct 17.
 Abstract

Hepatocellular carcinoma in HIV hepatitis C virus.
Puoti M, Rossotti R, Garlaschelli A, Bruno R.
 Curr Opin HIV AIDS. 2011 Sep 20.
Abstract

Clinical characteristics, staging and treatment of patients with hepatocellular carcinoma in clinical practice.
Prospective study of 136 patients.]
Gómez Rodríguez R, Romero Gutiérrez M, et al
Gastroenterol Hepatol. 2011 Sep 20..
 Abstract

Occurrence of Hepatocellular Carcinoma Was Not a Rare Event during and Immediately after
Antiviral Treatment in Japanese HCV-Positive Patients.
Kanda T, Imazeki F, Mikami S, et al
 Oncology. 2011 Aug 3;80(5-6):366-372.
Abstract

Level of Alpha-Fetoprotein Predicts Mortality among Patients with Hepatitis C-Related
Hepatocellular Carcinoma.
Tyson GL, Duan Z, Kramer JR, et al
 Clin Gastroenterol Hepatol. 2011 Aug 3.
 Abstract

Case report: A case of light chain deposition disease involving liver and stomach with
chronic hepatitis C virus infection and hepatocellular carcinoma.
 Kwon JH, Jeong SH, Kim JW,  et al
J Med Virol. 2011 May;83(5):810-4. .
 Abstract

Clinical features and prognosis in patients with hepatocellular carcinoma that developed
after hepatitis C virus eradication with interferon therapy.
 Nagaoki Y, Aikata H, Miyaki D, et al
J Gastroenterol. 2011 Mar 4.
Abstract

Eradication of Hepatitis C Virus Reduces the Risk of Hepatocellular Carcinoma in Patients
with Compensated Cirrhosis.
 Velosa J, Serejo F, Marinho R, Nunes J, Glória H
Dig Dis Sci. 2011 Mar 5.
Abstract

Steatohepatitic Hepatocellular Carcinoma (SH-HCC): A Distinctive Histological Variant of
HCC in Hepatitis C Virus-related Cirrhosis With Associated NAFLD/NASH.
 Salomao M, Yu WM, Brown RS Jr, et  al
Am J Surg Pathol. 2010 Nov;34(11):1630-6.
 Abstract

Hepatitis C virus infection and hepatocarcinogenesis.
 Szalay F.
Orv Hetil. 2010 Sep 19;151(38):1524-9
 Abstract

Diagnostic and treatment algorithm of the Japanese society of hepatology:
a consensus-based practice guideline.
 Izumi N.
 Oncology. 2010 Jul;78 Suppl 1:78-86
 Abstract

Does chemotherapy prevent HCV-related hepatocellular carcinoma? Cons.
 Craxì A, Cammà C.
Dig Liver Dis. 2010 Jul;42 Suppl 3:S287-92.
 Abstract

Effects of preceding interferon therapy on outcome after surgery for hepatitis C
virus-related hepatocellular carcinoma.
 Tomimaru Y, Nagano H, Eguchi H,  et al
J Surg Oncol. 2010 Jun 29.
Abstract
Inflammatory Bowel Disease
 
     Journal Papers, Abstracts, and Commentaries
 
  Hepatitis C Virus and Inflammatory Bowel Disease.
 Horn TL, Reynolds J, de Villiers W, Peña LR.
 Dig Dis Sci. 2008 Oct 31.
 Abstract		  
Non-Alcoholic Fatty Liver Disease
 
     Journal Papers, Abstracts, and Commentaries
 
 
Relation between Body Fat and Liver Fat Accumulation and Cytokine Pattern in
Non-Alcoholic Patients with Chronic HCV Infection.
 González-Reimers E, Castellano-Higuera A, Alemán-Valls R, et al
 Ann Nutr Metab. 2009 Oct 23;55(4):351-357
 Abstract

HCV and non-alcoholic fatty liver disease: similar risk factors for necro-inflammation,
fibrosis, and cirrhosis.
 Comparcola D, Alisi A, Nobili V.
 Clin Gastroenterol Hepatol. 2009 Sep 16.
 Abstract

  
Purpura
 
     Journal Papers, Abstracts, and Commentaries
 
  Purpura with Cold Urticaria in a Patient with Hepatitis C Virus Infection-Associated Mixed
Cryoglobulinemia Type III: Successful Treatment with Interferon-beta.
 Ito A, Kazama T, Ito K, Ito M.
IJ Dermatol 2003 Apr;30(4):321-5
 Abstract		  
Post-Transplantation HCV
 
 
Treatment of posttransplantation recurrence of hepatitis C with interferon and ribavirin:
Lessons on tolerability and efficacy.
 Narayanan Menon KV, Poterucha JJ, et al
 Liver Transpl 2002 Jul;8(7):623-9
 Abstract
 
Update on the Management of Hepatitis C in Liver Transplant Recipients.
 A Bobak D, Yadavalli G.
 Curr Infect Dis Rep 2002 Apr;4(2):105-111
 Abstract
 
Renal Disease
 
     Journal Papers, Abstracts, and Commentaries
 
Hepatitis C Infection and Chronic Renal Diseases.
 Perico N, Cattaneo D, Bikbov B, Remuzzi G.
Clin J Am Soc Nephrol. 2009 Jan 7.
 Abstract

Rapidly deteriorating renal function with membranoproliferative glomerulonephritis Type 1
associated with hepatitis C treated successfully with steroids and antiviral therapy: a case
report and review of literature.
 Ahmed MS, Wong CF, Shawki H, et al
Clin Nephrol. 2008 Apr;69(4):298-301
Abstract
 
  HCV-related cryoglobulinemic glomerulonephritis: implications of antiviral and immunosuppressive
therapies.
 Garini G, Allegri L, Lannuzzella F, et al 
Acta Biomed. 2007;78(1):51-9
 Abstract
Splenic Disease
 

     Journal Papers, Abstracts, and Commentaries

  Laparoscopic splenectomy with peginterferon and ribavirin therapy for patients with
hepatitis C virus cirrhosis and hypersplenism.
 Akahoshi T, Tomikawa M, Korenaga , et al
Surg Endosc. 2009 Aug 19|
 Abstract
Statin Hepatotoxicity
 

     Journal Papers, Abstracts, and Commentaries

  Incidence of Statin Hepatotoxicity in Patients With Hepatitis C.
 Khorashadi S, Hasson NK, Cheung RC. 
Clin Gastroenterol Hepatol. 2006 May 9;
Abstract
Steatosis
 
 
Hepatic steatosis and insulin resistance are associated with severe fibrosis in patients with
chronic hepatitis caused by HBV or HCV infection.
Petta S, Cammà C, Marco VD,  et al
 Liver Int. 2011 Apr;31(4):507-15
 Abstract

Hepatic steatosis and hepatitis C: Still unhappy bedfellows?
 Hwang SJ, Lee SD.
 J Gastroenterol Hepatol. 2011 Jan;26 Suppl 1:96-101.
 Abstract

FULL-TEXT PDF ARTICLE
 Steatosis and serum lipid patterns in patients with chronic viral hepatitis:
differences related to viral etiology.
 Vere CC, Neagoe D, Streba CT,  et al
Rom J Morphol Embryol. 2010;51(3):509-14
 Abstract

Hepatitis C virus-induced steatosis: an overview.
 Negro F.
Dig Dis. 2010;28(1):294-9
 Abstract
 
Hepatitis C virus, diabetes and steatosis: clinical evidence in favor of a linkage and role
of genotypes.
Mihm S.
Dig Dis. 2010;28(1):280-4.
 Abstract

Hepatic Steatosis in Genotype 4 Chronic Hepatitis C Patients: Implication for Therapy.
Khattab MA, Abdel-Fattah ME, Eslam M,  et al
J Clin Gastroenterol. 2010 Feb 25.
 Abstract

Prevalence and predictors of hepatic steatosis in adults with newly diagnosed chronic liver
disease due to hepatitis C.
 Hayman AV, Sofair AN, Manos MM, et al 
Medicine (Baltimore). 2009 Sep;88(5):302-6.
 Abstract

Insulin resistance and steatosis in chronic hepatitis C.
Machado MV, Cortez-Pinto H
 Ann Hepatol. 2009;8 Suppl 1:S67-75.
 Abstract

Influence of insulin resistance on Hepatic Fibrosis and Steatosis in HCV Monoinfected compared
with HIV-HCV co-infected patients.
 Halfon P, Pénaranda G, Carrat F, et al
Aliment Pharmacol Ther. 2009 Mar 9.
Abstract
 
Review of patients with hepatosteatosis and chronic hepatitis C.
 Smoliski P, Pazgan-Simon M, Zuwała-Jagiełło J, et al 
Przegl Epidemiol. 2008;62(3):571-9.
 Abstract
 
Liver Steatosis: Investigation of Opposed-Phase T1-weighted Liver MR Signal Intensity Loss and
Visceral Fat Measurement as Biomarkers.
 Bahl M, Qayyum A, Westphalen AC, et al
Radiology. 2008 Oct;249(1):160-6.
 Abstract
 
A WEEK IN REVIEW FEATURED REPORT
Daily cannabis use: a novel risk factor of steatosis severity in patients with chronic hepatitis C.
Hézode C, Zafrani ES, Roudot-Thoraval F, et al
 Gastroenterology. 2008 Feb;134(2):432-9.
 Abstract
 
Connective tissue growth factor, steatosis and fibrosis in patients with chronic hepatitis C.
 Hora C, Negro F, Leandro G, et al
Liver Int. 2007 Nov 1;
 Abstract
 
Correlation of hepatic steatosis with body mass index, serum ferritin level and hepatic fibrosis in
Japanese patients with chronic hepatitis C.
 Sumida Y, Kanemasa K, Fukumoto K, et al 
Hepatol Res. 2007 Apr;37(4):263-9.
 Abstract
 
Clinical multicenter study of U.S. Veterans.
 Hu KQ, Currie SL, Shen H 
Abstract
 
FULL-TEXT ARTICLE
Mechanisms and significance of liver steatosis in hepatitis C virus infection.
 Negro F.  
World J Gastroenterol. 2006 Nov 14;12(42):6756-6765.
 Paper
 
Hepatic Steatosis Is Associated with Fibrosis, Nucleoside Analogue Use, and
Hepatitis C Virus Genotype 3 Infection in HIV-Seropositive Patients.
 McGovern BH, Ditelberg JS, Taylor LE, et al 
Clin Infect Dis. 2006 Aug 1;43(3):365-72.
 Abstract
 
Impact of human immunodeficiency virus infection on the prevalence and severity of steatosis in
patients with chronic hepatitis C virus infection.
 Gaslightwala I, Bini EJ. 
Hepatol. 2006 Mar 13
Abstract
 
FULL-TEXT ARTICLE
 Hepatitis C virus (HCV) infection and hepatic steatosis.
 Yoon EJ, Hu KQ. 
Int J Med Sci. 2006;3(2):53-6
Paper
 
Review article: hepatitis C virus-associated steatosis - pathogenic mechanisms and clinical
implications.
 Adinolfi LE, Durante-Mangoni E, Zampino R, Ruggiero G.  
Aliment Pharmacol Ther. 2005 Nov;22 Suppl 2:52-5.
 Abstract
 
Metabolic aspects of hepatitis C viral infection: steatohepatitis resembling but distinct from
NASH.
 Koike K, Moriya K.
 J Gastroenterol. 2005 Apr;40(4):329-36.
 Abstract
 
Severe steatosis as the initial histologic manifestation of recurrent hepatitis C genotype 3.
 Gordon FD, Pomfret EA, Pomposelli JJ, et al 
Hum Pathol. 2004 May;35(5):636-8.
 Abstract
 
Steatosis and liver cell apoptosis in chronic hepatitis C: a mechanism for increased liver injury.
 Walsh MJ, Vanags DM, Clouston AD, et al 
Hepatology. 2004 May;39(5):1230-8
 Abstract

Steatosis in chronic hepatitis C: Relative contributions of obesity, diabetes mellitus, and alcohol.
Monto A, Alonzo J, |Watson JJ, et al.   
 Hepatology 2002 Sep;36(3):729-36
 Abstract

  
 

HCV Main Page Main New/Newsworthy    Home Page    

HCV Clinical Variants